All these findings accentuate the sheer requisite of anti-glycation compounds/AGE/RAGE antagonists as potentially active components of successful cancer treatment, considering the multiplicity of AGEs with vital role in inducing RAGE and its other ligands. This evidence concerns the gene AGER and cancer.